Spatial immune architecture and tumor–T cell proximity are associated with response to neoadjuvant atezolizumab in muscle-invasive bladder cancer

Posters Nov 7, 2026
Oncology
|
Histopathology

November 7, 2026

Spatial immune architecture and tumor–T cell proximity are associated with response to neoadjuvant atezolizumab in muscle-invasive bladder cancer

Featured Resources

See All Experts' Insights
Cellcarta Tagline Logo Posters
Nov 7, 2026

Construction and Validation of Alternative Biomarker Immunohistochemistry Assays on the Path to Companion Diagnostics
Cellcarta Tagline Logo Posters
Nov 7, 2026

Implementation and cross-validation of a Lunaphore COMET hyperplex assay within a global CRO infrastructure
Patrick Reese Biotechne Spatial Video Thumbnail 1024x576 Videos
Sep 25, 2026

Scaling Consistent Biomarker Data Across CellCarta's Global Lab Network
See All Experts' Insights

One global CRO for your whole therapeutic development journey

CellCarta has the multi-modal capabilities, scientific depth, and harmonized global footprint needed to advance even the most complex programs in precision medicine.

Talk to our Team
cta banner